The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding

Cell Rep. 2021 May 25;35(8):109184. doi: 10.1016/j.celrep.2021.109184.

Abstract

Autophagy dysregulation is implicated in metabolic diseases, including type 2 diabetes. However, the mechanism by which the autophagy machinery regulates metabolism is largely unknown. Autophagy is generally considered a degradation process via lysosomes. Here, we unveil a metabolically important non-cell-autonomous, non-degradative mechanism regulated by the essential autophagy protein Becn1 in adipose tissue. Upon high-fat diet challenge, autophagy-hyperactive Becn1F121A mice show systemically improved insulin sensitivity and enhanced activation of AMP-activated protein kinase (AMPK), a central regulator of energy homeostasis, via a non-cell-autonomous mechanism mediated by adiponectin, an adipose-derived metabolic hormone. Adipose-specific Becn1F121A expression is sufficient to activate AMPK in non-adipose tissues and improve systemic insulin sensitivity by increasing adiponectin secretion. Further, Becn1 enhances adiponectin secretion by interacting with components of the exocyst complex via the coiled-coil domain. Together, our study demonstrates that Becn1 improves insulin sensitivity by facilitating adiponectin secretion through binding the exocyst in adipose tissue.

Keywords: AMPK; Becn1; Sec6; adiponectin; adipose tissue; autophagy; exocyst; glucose tolerance; insulin sensitivity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Adiponectin / metabolism*
  • Animals
  • Autophagy
  • Beclin-1 / metabolism*
  • Humans
  • Insulin / metabolism*
  • Lysosomes / metabolism*
  • Mice
  • Transfection

Substances

  • Adiponectin
  • Beclin-1
  • Becn1 protein, mouse
  • Insulin
  • AMP-Activated Protein Kinases